Correlation Between OrganiGram Holdings and Cyclo Therapeutics
Can any of the company-specific risk be diversified away by investing in both OrganiGram Holdings and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OrganiGram Holdings and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OrganiGram Holdings and Cyclo Therapeutics, you can compare the effects of market volatilities on OrganiGram Holdings and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OrganiGram Holdings with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of OrganiGram Holdings and Cyclo Therapeutics.
Diversification Opportunities for OrganiGram Holdings and Cyclo Therapeutics
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between OrganiGram and Cyclo is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding OrganiGram Holdings and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and OrganiGram Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OrganiGram Holdings are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of OrganiGram Holdings i.e., OrganiGram Holdings and Cyclo Therapeutics go up and down completely randomly.
Pair Corralation between OrganiGram Holdings and Cyclo Therapeutics
Considering the 90-day investment horizon OrganiGram Holdings is expected to under-perform the Cyclo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, OrganiGram Holdings is 7.9 times less risky than Cyclo Therapeutics. The stock trades about -0.3 of its potential returns per unit of risk. The Cyclo Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 14.00 in Cyclo Therapeutics on August 27, 2024 and sell it today you would earn a total of 0.00 from holding Cyclo Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
OrganiGram Holdings vs. Cyclo Therapeutics
Performance |
| Timeline |
| OrganiGram Holdings |
| Cyclo Therapeutics |
OrganiGram Holdings and Cyclo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with OrganiGram Holdings and Cyclo Therapeutics
The main advantage of trading using opposite OrganiGram Holdings and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OrganiGram Holdings position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.| OrganiGram Holdings vs. Cronos Group | OrganiGram Holdings vs. Aurora Cannabis | OrganiGram Holdings vs. SNDL Inc | OrganiGram Holdings vs. Canopy Growth Corp |
| Cyclo Therapeutics vs. Eliem Therapeutics | Cyclo Therapeutics vs. HCW Biologics | Cyclo Therapeutics vs. Scpharmaceuticals | Cyclo Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |